Global Oncology Cancer Drugs Market Revenue Projected To Surpass $289 Billion By 2030
Cancer is a non-treatable chronic disease that has posed a challenge to the medical fraternity for decades.
- Cancer is a non-treatable chronic disease that has posed a challenge to the medical fraternity for decades.
- The entire medical research fraternity has prioritized cancer research in order to find new ways of treatment and analysis.
- According to Nova one advisor, the global Oncology Cancer Drugs market was valued at USD 147.2 billion in 2021 and it is expected to hit around USD 289.2 billion by 2030 with a CAGR of 8.4% during the forecast period 2022 to 2030.
- The article continued: “Drugs such as morphine, fentanyl, acetaminophen, nonsteroidal anti-inflammatory drugs (NSAIDs), and others are used extensively in treating cancer pain in patients with lung cancer, bone cancer, and other types of cancer.